Brian Halak

Domain Associates

ABOUT Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on investing in life science companies that advance human health. Domain's focused network, deep experience, and dependable reputation of this team have made it one of the top private-equity groups participating in healthcare investing. With $2.4 billion of capital under management, Domain invests in three major segments: pharmaceuticals, diagnostics, and medical devices. EXPERIENCE Domain has raised eight funds and has been involved in the formation of more than 250 portfolio companies. The partners of Domain have a total of close to 200 person-years of experience among them in the healthcare and venture capital industries. Representative past investments include Amgen, Amylin Pharmaceuticals, BiPar Sciences, Biosite, Dura Pharmaceuticals and Pharmion. Our companies have created a number of U.S. approved products that have advanced human health. LEADERSHIP We have developed innovative investment models, such as specialty pharma and Japanese in-licensing, which have proven successful and have been widely emulated in the life science industry. We are engaged in new collaborations, including Domain's investments in Russia and China with Rusnano and Beijing Elite, respectively.